GUILLERMO JOSÉ
MARTÍNEZ DÍAZ-GUERRA
Profesor asociado de Ciencias de la Salud
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (61)
2022
-
Bone loss induced by cancer treatments in breast and prostate cancer patients
Clinical and Translational Oncology, Vol. 24, Núm. 11, pp. 2090-2106
-
Clinical practice recommendations for the diagnosis and treatment of X-linked hypophosphatemia: A consensus based on the ADAPTE method
Medicina Clinica, Vol. 159, Núm. 3, pp. 152.e1-152.e12
-
Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients (Clinical and Translational Oncology, (2022), 24, 11, (2090-2106), 10.1007/s12094-022-02872-1)
Clinical and Translational Oncology
-
Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)
Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12
2021
-
Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency
Growth Hormone and IGF Research, Vol. 60-61
-
Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly
Clinical Endocrinology, Vol. 95, Núm. 1, pp. 58-64
2020
-
Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer
Medical sciences (Basel, Switzerland), Vol. 8, Núm. 4
-
Hypophosphataemic Rickets: Similar Phenotype of Different Diseases
Advances in Therapy, Vol. 37, pp. 80-88
-
Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy
Cancer Medicine, Vol. 9, Núm. 16, pp. 5746-5755
2019
-
Different development of serum sclerostin compared to other bone remodeling markers in the first year after a liver transplant
Revista de Osteoporosis y Metabolismo Mineral
2018
-
Consensus document on osteoporosis in males
Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 9-16
-
Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy
Endocrine, Vol. 62, Núm. 1, pp. 166-173
2016
-
Serum Levels of Osteocalcin and Insulin Resistance in Patients with Impaired Glucose Tolerance or New-Onset Diabetes Mellitus after Liver Transplantation
Hormone and Metabolic Research, Vol. 48, Núm. 5, pp. 325-330
-
Seven years of follow up of trabecular bone score, bone mineral density, body composition and quality of life in adults with growth hormone deficiency treated with rhGH replacement in a single center
Therapeutic Advances in Endocrinology and Metabolism, Vol. 7, Núm. 3, pp. 93-100
-
Trabecular bone score in patients with liver transplants after 1 year of risedronate treatment
Transplant International, Vol. 29, Núm. 3, pp. 331-337
-
Vitamin D deficiency: Are we identifying it well?
Revista de Osteoporosis y Metabolismo Mineral
2013
-
Bone mineral density and vitamin D levels in erythropoietic protoporphyria
Endocrine, Vol. 44, Núm. 3, pp. 803-807
-
Comparative effects of teriparatide and risedronate in glucocorticoid- induced osteoporosis in men: 18-month results of the EuroGIOPs trial
Journal of Bone and Mineral Research, Vol. 28, Núm. 6, pp. 1355-1368
-
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
Osteoporosis International, Vol. 24, Núm. 12, pp. 2971-2981
-
Erratum: Bone mineral density and vitamin D levels in erythropoietic protoporphyria (Endocrine (DOI 10.1007/s12020-013-9934-x))
Endocrine